Palliation of malignant dysphagia from oesophageal cancer. Rotterdam Oesophageal Tumor Study Group.
Palliative therapies for advanced oesophageal cancer include surgery, radiation therapy, chemotherapy, endoscopic procedures and combinations of these. Of the non-endoscopic modalities is external beam radiation therapy (EBRT) effective and non-invasive. A disadvantage is that relief of dysphagia only occurs over a period of 4-6 weeks. Brachytherapy is more rapid in locally controlling tumour growth and in relieving dysphagia. One of the more commonly used endoscopic procedures is laser therapy, which provides symptomatic relief with low complication rates. Recurrent dysphagia is a problem necessitating repeated treatment sessions. Self-expanding metal stents offer a high degree of palliation and are associated with fewer complications compared with prosthetic tubes. Longer palliation and perhaps even longer survival might be achieved by the combination of different therapies. Most promising are the combination of EBRT plus brachytherapy or chemoradiation. Now is the time to determine which treatment (combination) is best for individual patients.
Siersema
P D
PD
Dept. of Gastroenterology and Hepatology (Internal Medicine II), University Hospital Rotterdam-Dijkzigt, The Netherlands.
Dees
J
J
van Blankenstein
M
M
D001918:Brachytherapy / Q000379:methods; D003131:Combined Modality Therapy; D003680:Deglutition Disorders / Q000209:etiology* / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D004938:Esophageal Neoplasms / Q000150:complications* / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D004945:Esophagoscopy / Q000379:methods; D006801:Humans; D053685:Laser Therapy / Q000379:methods; D010166:Palliative Care / Q000379:methods*; D012008:Recurrence; D015607:Stents